Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other financing activities: 2017-2025

Historic Other financing activities for Mesa Laboratories (MLAB) over the last 8 years, with Sep 2025 value amounting to $3.8 million.

  • Mesa Laboratories' Other financing activities fell 0.65% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 13.62%. This contributed to the annual value of $13.1 million for FY2025, which is 10.10% up from last year.
  • Mesa Laboratories' Other financing activities amounted to $3.8 million in Q3 2025, which was down 1.78% from $3.9 million recorded in Q2 2025.
  • Mesa Laboratories' Other financing activities' 5-year high stood at $14.5 million during Q1 2025, with a 5-year trough of $2.0 million in Q3 2021.
  • For the 3-year period, Mesa Laboratories' Other financing activities averaged around $6.0 million, with its median value being $3.8 million (2025).
  • Per our database at Business Quant, Mesa Laboratories' Other financing activities soared by 1,007.44% in 2021 and then slumped by 44.48% in 2022.
  • Quarterly analysis of 5 years shows Mesa Laboratories' Other financing activities stood at $3.7 million in 2021, then tumbled by 44.48% to $2.1 million in 2022, then surged by 45.57% to $3.0 million in 2023, then grew by 8.22% to $3.2 million in 2024, then fell by 0.65% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.9 million for Q2 2025, and $14.5 million during Q1 2025.